| Good Samaritan Society Of Barbour County | |
| 216 Samaritan Circle, Belington, West Virginia 26250 | |
| (304) 823-2555 | |
| Name | Good Samaritan Society Of Barbour County |
|---|---|
| Location | 216 Samaritan Circle, Belington, West Virginia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 57 |
| Occupancy Rate | 71.23% |
| Medicare ID (CCN) | 515116 |
| Legal Business Name | The Evangelical Lutheran Good Samaritan Society |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1225029432 |
| Organization Name | THE EVANGELICAL LUTHERAN GOOD SAMARITAN SOCIETY |
| Doing Business As | GOOD SAMARITAN SOCIETY - BARBOUR COUNTY |
| Address | Rr 3 Box 15c, Belington, WV 26250 |
| Phone Number | 304-823-2555 |
News Archive
Scientists from Freie Universität Berlin and Charité - Universitätsmedizin Berlin at Campus Benjamin Franklin have developed a new class of pain medication.
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, Massachusetts General Hospital (MGH) investigators report the first preclinical study combining antiangiogenic and anti-HER2 drugs in an animal model of brain metastatic breast cancer.
Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.
According to tax records unearthed by Bloomberg News, the health insurance lobby secretly gave $86.2 million to the U.S. Chamber of Commerce in 2009 to try to prevent the health care bill from becoming law. The huge contribution — 40 percent of the chamber's spending for that year — allowed the group to run ads against the bill without tainting the insurance industry, which was negotiating with Democrats on the bill at the same time (11/22).
› Verified 9 days ago
| NPI Number | 1811670607 |
| Organization Name | BELINGTON SNF OPERATIONS LLC |
| Address | 216 Samaritan Cir, Belington, WV 26250 |
| Phone Number | 304-823-2555 |
News Archive
Scientists from Freie Universität Berlin and Charité - Universitätsmedizin Berlin at Campus Benjamin Franklin have developed a new class of pain medication.
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, Massachusetts General Hospital (MGH) investigators report the first preclinical study combining antiangiogenic and anti-HER2 drugs in an animal model of brain metastatic breast cancer.
Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.
According to tax records unearthed by Bloomberg News, the health insurance lobby secretly gave $86.2 million to the U.S. Chamber of Commerce in 2009 to try to prevent the health care bill from becoming law. The huge contribution — 40 percent of the chamber's spending for that year — allowed the group to run ads against the bill without tainting the insurance industry, which was negotiating with Democrats on the bill at the same time (11/22).
› Verified 9 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Scientists from Freie Universität Berlin and Charité - Universitätsmedizin Berlin at Campus Benjamin Franklin have developed a new class of pain medication.
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, Massachusetts General Hospital (MGH) investigators report the first preclinical study combining antiangiogenic and anti-HER2 drugs in an animal model of brain metastatic breast cancer.
Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.
According to tax records unearthed by Bloomberg News, the health insurance lobby secretly gave $86.2 million to the U.S. Chamber of Commerce in 2009 to try to prevent the health care bill from becoming law. The huge contribution — 40 percent of the chamber's spending for that year — allowed the group to run ads against the bill without tainting the insurance industry, which was negotiating with Democrats on the bill at the same time (11/22).
› Verified 9 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 16.3 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.17 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 37.21 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.79 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.61 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.83 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.51 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 14.56 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 32.53 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 12 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 25.61 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 9.68 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 18.27 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.11 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 58.29 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 67.82 | 82.93 |
News Archive
Scientists from Freie Universität Berlin and Charité - Universitätsmedizin Berlin at Campus Benjamin Franklin have developed a new class of pain medication.
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, Massachusetts General Hospital (MGH) investigators report the first preclinical study combining antiangiogenic and anti-HER2 drugs in an animal model of brain metastatic breast cancer.
Rush University Medical Center is participating in a clinical trial to evaluate the potential benefit of the first major innovation in 20 years for the treatment of growth failure.
According to tax records unearthed by Bloomberg News, the health insurance lobby secretly gave $86.2 million to the U.S. Chamber of Commerce in 2009 to try to prevent the health care bill from becoming law. The huge contribution — 40 percent of the chamber's spending for that year — allowed the group to run ads against the bill without tainting the insurance industry, which was negotiating with Democrats on the bill at the same time (11/22).
› Verified 9 days ago
Good Samaritan Society Of Barbour County Location: 216 Samaritan Circle, Belington, West Virginia 26250 Phone: (304) 823-2555 |